Navidea Biopharmaceuticals

📍 Dublin, United States👥 14 employees💰 Last funded Dec 2018
Biotechnology Research🌐 navidea.com
Website LinkedIn
Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Applying our Manocept™ technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases, with an initial focus on personalized Rheumatoid Arthritis diagnostics. The company, founded in 1983, maintains headquarters in Dublin, Ohio.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals has 1 investor on record on gritt.io.
When did Navidea Biopharmaceuticals last raise funding?
The most recent investment in Navidea Biopharmaceuticals recorded on gritt.io was in December 2018.
What industry is Navidea Biopharmaceuticals in?
Navidea Biopharmaceuticals operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Navidea Biopharmaceuticals based?
Navidea Biopharmaceuticals is headquartered in Dublin, United States.